IT
Trace Biosciences develops fluorescent contrast agents that specifically target nerves during surgical procedures, enhancing visualization and precision. This technology aims to improve surgical outcomes by reducing the risk of nerve damage and associated complications.
Portland, United StatesFounded 2019
Updated 2 months ago
Funding
$52.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NFounders
Founder details are not available yet.
Product
Features
- Trace Biosciences develops fluorescent contrast agents that specifically target nerves during surgical procedures, enhancing visualization and precision. This technology aims to improve surgical outcomes by reducing the risk of nerve damage and associated complications.